Dry Eye Disease Market By Product Type (Artificial Tears, Anti-inflammatory Drugs, Punctal Plugs, Secretagogue), By Distribution Channel (Hospital Pharmacies, Hospital Pharmacies, Online Pharmacies), Industry Analysis, Trends, and Forecast 2019 – 2025

Report ID: BMRC 257 | Number of pages: 200 | Publish Date: May 2019 | Publisher: BMRC | Category: Lifesciences and Healthcare
Dry Eye Disease Market is valued around USD 2796.8 Million in 2018 and expected to reach USD 3778.1 Million by 2025 with the CAGR of 4.7% over the forecast period. Increase in geriatric population and various environmental factors are the key drivers for Global Dry Eye Disease Market.

Dry eye disease market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about dry eye disease market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with product type, distribution channel.

Dry eye disease is caused due to the lack of tears or lubrication in eyes which led to the burning sensation and redness in eyes. These tears provide lubrication and each blink spread tears evenly and provide nourishment to the eyes. When the production and drainage of tears are not balanced then it leads to the dry eye disease. This condition is most commonly occurs in older population and there are various environmental conditions which are responsible for such condition in young adults as well. The few symptoms experienced by the people suffering from dry eye disease are irritation, burning sensation, blurred vision and advanced stage may also lead to the vision impairment.

There are various factors driving the growth of the dry eye disease market, one of the major factors driving the growth of this market is increasing geriatric population. Due to the weakening of muscles and glands in geriatric people it is most common condition among them. As per Population Reference Bureau report, the number of Americans ages 65 and older is projected to more than double from 46 million today to over 98 million by 2060, and the 65-and-older age group’s share of the total population will rise to nearly 24 percent from 15 percent.  Furthermore, there are various research and development activities carried by major players which led to the development of novel drugs and devices for the treatment of this condition. Moreover, there is a constant increase in population and various other environmental factors which may affect the tear production which led to the dry eye disease. However, stringent regulations and high cost of dry eye disease are expected inhibit the growth of dry eye disease market over the forecast period.

Global dry eye disease market report covers prominent players like Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Allergan plc, Shire plc, TRB Chemedica International SA, Mitotech S.A., Sun Pharmaceutical Industries Ltd., Senju Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., Valeant Pharmaceuticals International, Inc., Otsuka Pharmaceutical Co., Ltd., Novartis AG, FCI S.A.S. and others.

Dry Eye Disease Market Segmentation –

By Product Type 

Artificial Tears
Anti-inflammatory Drugs
Punctal Plugs
Secretagogue
By Distribution Channel 

Hospital Pharmacies
Independent Pharmacies and Drug Stores
Online Pharmacies
By Region

North America
U.S.
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Dry Eye Disease Market key Players
Santen Pharmaceutical Co., Ltd.
Johnson & Johnson
Allergan plc
Shire plc
TRB Chemedica International SA
Mitotech S.A.
Sun Pharmaceutical Industries Ltd.
Senju Pharmaceutical Co., Ltd.
Sentiss Pharma Pvt. Ltd.
Chapter – Report Methodology
Research Process
Primary Research
Secondary Research
Market Size Estimates
Data Triangulation
Forecast Model
USP’s of Report
Report Description
Chapter – Global Dry Eye Disease Market Overview: Qualitative Analysis
Market Introduction
Executive Summary
Global Dry Eye Disease Market Classification
Market Drivers
Market Restraints
Market Opportunity
Dry Eye Disease Market: Trends
Porter’s Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Consumers
Threat of New Entrants
Threat of Substitute Product and Services
Competitive Rivalry within the Industry
Market Attractiveness Analysis
Market Attractiveness Analysis by Segmentation
Market Attractiveness Analysis by Region
Chapter – Global Dry Eye Disease Market Overview: Quantitative Analysis
Global Dry Eye Disease Market Consumption, Market Share ( %) and Growth Rate, 2015- 2025
Global Dry Eye Disease Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2015- 2025
Chapter – Global Dry Eye Disease Market Analysis: by Product Type
Chapter – Global Dry Eye Disease Market Analysis: by Distribution Channel
Chapter – Global Dry Eye Disease Market Analysis: by Manufacturer
Global Dry Eye Disease Market Revenue (USD Million), by Manufacturer, 2015 – 2018
Global Dry Eye Disease Market Consumption, Manufacturer, 2015 – 2018
Global Dry Eye Disease Market Share (%), by Manufacturer, 2018
Global Dry Eye Disease Market Price (USD/Unit), by Manufacturer, 2015 – 2018
Global Dry Eye Disease Market Revenue Growth Rate (%), by Manufacturer, 2015 – 2018
Merger & Acquisition
Collaborations and Partnership
New Product Launch
Chapter – Dry Eye Disease Market: Regional Analysis
North America
North America Dry Eye Disease Market Revenue (USD Million) and Growth Rate (%), 2015 – 2025.
North America Dry Eye Disease Market Revenue (USD Million) By Country, 2015 – 2025.
North America Dry Eye Disease Revenue Market Share (%) By Country, 2015 – 2025.
North America Dry Eye Disease Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015 – 2025.
North America Dry Eye Disease Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015 – 2025.
North America Dry Eye Disease Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015 – 2025.
Europe
Asia Pacific
Latin America
Middle East & Africa
Chapter – Company Profiles
Santen Pharmaceutical Co., Ltd.
Overview
Financials
Product portfolio
Dry Eye Disease Market Revenue (USD Million), Consumption  and Market Share (%), 2015 – 2018
Dry Eye Disease Sales Market Share (%), 2015 – 2018
Business strategy
Recent developments
Johnson & Johnson
Allergan plc
Shire plc
TRB Chemedica International SA
Mitotech S.A.
Sun Pharmaceutical Industries Ltd.
Senju Pharmaceutical Co., Ltd.
Sentiss Pharma Pvt. Ltd.
Valeant Pharmaceuticals International, Inc.
Otsuka Pharmaceutical Co., Ltd.
Novartis AG
FCI S.A.S.
Others
Chapter – Market Research and Findings
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.